. . . . . . . . . . . . . . "Methylphenidate Hydrochloride is indicated as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity" . . . . "RSA" . "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB" . "DkAjfxxTQhAt2y8Mdxxmnbux6zOVZEp9/vDg9dsDFGpin+dmSwkUJhCLI3M9bOMk58crAs8rYIXu2fv2OCK3/zAJz9gVeu4Ieo5FLbGfxRABlpVabs9IX005HXwU5pEajt/r0Hf8WDjdXS/rKahyXn5Iz+WIp0piRkKq6SLpJiw=" . . "2021-04-18T11:43:31.381+02:00"^^ . . . . .